Related Experiment Video
Updated: Jan 10, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
JC polyomavirus neuroinvasion across the blood-brain barrier: Current understanding and emerging perspectives
Avraham S Lukacher1, Wenqing Yuan2, Bethany A O'Hara2
1Washington University School of Medicine, St. Louis, MO, 63108, United States of America.
Abstract:
JC Polyomavirus (JCPyV) is the causative agent of progressive multifocal leukoencephalopathy (PML), an often-fatal demyelinating disease. Unfortunately, a diagnosis of PML occurs only after patients have suffered irreversible neuropathologies. One requirement for the development of PML is for JCPyV to enter the brain, but the mechanisms responsible for neuroinvasion have not been well established. The blood-brain barrier (BBB) is a potential site for JCPyV neuroinvasion. JCPyV DNA is found in the vascular endothelium in postmortem brain tissue from PML patients, and demyelinating lesions commonly emerge around vascularized sites. This review explores three potential pathways that may underlie JCPyV traversal across the BBB: diapedesis ("Trojan Horse") via JCPyV-associated B cells, paracellular passage, and transcytosis. Elucidating the route and mechanism of JCPyV neuroinvasion will deepen our understanding of how the virus enters the brain before the manifestation of PML neuropathologies. Additionally, we discuss current limitations of in vitro BBB modeling and propose future approaches to more accurately capture the physiological dynamics underlying JCPyV neuroinvasion.
Insights
JC Polyomavirus (JCPyV) causes progressive multifocal leukoencephalopathy (PML). This review explores how JCPyV crosses the blood-brain barrier (BBB), a crucial step for brain invasion and disease development.
Area of Science:
- Neurovirology
- Immunology
- Cell Biology
Background:
- JC Polyomavirus (JCPyV) is the etiological agent of progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease.
- PML diagnosis often follows irreversible neuropathology, highlighting the need to understand JCPyV neuroinvasion mechanisms.
- The blood-brain barrier (BBB) is a critical interface for JCPyV entry into the central nervous system.
Purpose of the Study:
- To review potential pathways for JCPyV traversal across the BBB.
- To elucidate mechanisms of JCPyV neuroinvasion.
- To discuss limitations in current in vitro BBB models for studying JCPyV.
Main Methods:
- Review of existing literature on JCPyV, PML, and BBB function.
- Analysis of JCPyV DNA presence in vascular endothelium of PML patients.
- Exploration of three proposed JCPyV BBB crossing mechanisms: diapedesis, paracellular passage, and transcytosis.
Main Results:
- JCPyV DNA is detected in the vascular endothelium of postmortem brain tissue from PML patients.
- Demyelinating lesions in PML often occur near vascularized areas, suggesting a vascular route of entry.
- Three potential JCPyV neuroinvasion pathways across the BBB are identified: "Trojan Horse" diapedesis, paracellular passage, and transcytosis.
Conclusions:
- Understanding JCPyV neuroinvasion pathways is key to comprehending PML pathogenesis before irreversible damage.
- Further research into JCPyV-BBB interactions is needed to develop preventative or therapeutic strategies.
- Improved in vitro BBB models are required to accurately simulate JCPyV neuroinvasion dynamics.
More Related Videos
Related Concept Videos
The Blood-brain Barrier
EPS and iPS Cells in Disease Research
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Mechanisms of Retrovirus-induced Cancers

